• STJ70461 Immunofluorescence analysis of paraformaldehyde fixed HeLa cells, permeabilized with 0. 15% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml) , showing cytoplasmic and nuclear staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml).

Anti-ORP7/OSBPL7 antibody (C-Term) (STJ70461)

SKU:
STJ70461-100

Shipping:
Free Shipping
Current Stock:
Host: Goat
Applications: Pep-ELISA/IF
Reactivity: Human/Mouse/Rat/Dog/Pig/Cow
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Goat polyclonal antibody anti-ORP7/OSBPL7 (C-Term) is suitable for use in ELISA and Immunofluorescence research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA
Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Concentration: 0.5 mg/mL
Dilution Range: IF-Strong expression of the protein seen in the cytoplasm and nuclei of HeLa cells. 10µg/ml
ELISA-antibody detection limit dilution 1:32000.
Storage Instruction: Store at-20°C on receipt and minimise freeze-thaw cycles.
Gene Symbol: OSBPL7
Gene ID: 114881
Uniprot ID: OSBL7_HUMAN
Immunogen Region: C-Term
Accession Number: NP_665741.1
Immunogen Sequence: EPGYGNMDGAVLW
Protein Name Oxysterol-Binding Protein-Related Protein 7
Orp-7
Osbp-Related Protein 7
Database Links Reactome: R-HSA-192105
Cellular Localisation Cytoplasm
Cytosol
Endoplasmic Reticulum Membrane
Cell Membrane
Alternative Antibody Names Anti-Oxysterol-Binding Protein-Related Protein 7 antibody
Anti-Orp-7 antibody
Anti-Osbp-Related Protein 7 antibody
Anti-OSBPL7 antibody
Anti-ORP7 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance